message from dr. burkhart and dr. hoff
Published 3 years ago • 7.1K plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
2:01
covid-19: ontario minister asks for investigation over reports doctor giving vaccine exemptions
-
0:50
phase ii trial of ker-050 in patients with myelofibrosis
-
2:09
keynote-240: pembrolizumab in advanced hcc
-
1:32
asco 2021 - sarah e hoffe, md - abstract tps4175
-
0:49
covid-19 vaccine: a message from dr. matt hoffman
-
1:10
keynote-811: hrqol pembro plus tras and chemo in first-line her2 advanced gastric cancer
-
43:39
perspectives on the pandemic | "blood clots and beyond" | episode 15
-
5:23
dr. joe schwarcz explains graphene face masks
-
43:59
34 first line therapy for her2- pdl1- cldn18.2 gea
-
31:53
hodgkin lymphoma: key info for hcps
-
3:22
keynote-224: pembrolizumab monotherapy for previously untreated hcc
-
0:31
“layers of protection mab” :30 radio (covid/flu)
-
2:09
cartitude-1: cilta-cel improves hrqol for patients with myeloma
-
0:16
"facing the flu" :15 (flu)
-
5:59
frontline lenvatinib vs sorafenib in hcc
-
3:36
hrc50 | human rights council updated on the human rights situation in ukraine
-
1:22
charles fuchs, md: bevacizumab plus chemotherapy
-
1:04:34
anca-associated vasculitis: plasma exchange, glucocorticoids and avacopan - pwr (nov 2024)
-
6:45
phase i trial of a fcrh5-targeted bite in r/r myeloma
-
1:36
chemotherapy and allohsct in the treatment of all
-
2:31
cilta-cel achieves deep and durable responses for r/r multiple myeloma
-
8:20
updates on the horizon study: melflufen in r/r multiple myeloma